v3.20.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2018   57,968,493      
Beginning balance at Dec. 31, 2018 $ 705,009 $ 58 $ 957,631 $ (244,166) $ (8,514)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (in shares)   9,319      
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings 0        
Exercise of stock options (in shares)   211,506      
Exercise of stock options 1,928   1,928    
Stock-based compensation expense 9,584   9,584    
Net loss (21,554)     (21,554)  
Foreign currency translation adjustment (372)       (372)
Ending balance (in shares) at Mar. 31, 2019   58,189,318      
Ending balance at Mar. 31, 2019 694,595 $ 58 969,143 (265,720) (8,886)
Beginning balance (in shares) at Dec. 31, 2018   57,968,493      
Beginning balance at Dec. 31, 2018 705,009 $ 58 957,631 (244,166) (8,514)
Increase (Decrease) in Stockholders' Equity          
Net loss (49,526)        
Foreign currency translation adjustment 1,871        
Ending balance (in shares) at Jun. 30, 2019   63,231,376      
Ending balance at Jun. 30, 2019 861,049 $ 63 1,161,321 (293,692) (6,643)
Beginning balance (in shares) at Mar. 31, 2019   58,189,318      
Beginning balance at Mar. 31, 2019 694,595 $ 58 969,143 (265,720) (8,886)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (in shares)   348,418      
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (2,558)   (2,558)    
Issuance of common stock in connection with business combination, net of offering costs (in shares)   4,608,101      
Issuance of common stock in connection with business combination, net of offering costs 184,322 $ 5 184,317    
Exercise of stock options (in shares)   85,539      
Exercise of stock options 452   452    
Stock-based compensation expense 9,967   9,967    
Net loss (27,972)     (27,972)  
Foreign currency translation adjustment 2,243       2,243
Ending balance (in shares) at Jun. 30, 2019   63,231,376      
Ending balance at Jun. 30, 2019 $ 861,049 $ 63 1,161,321 (293,692) (6,643)
Beginning balance (in shares) at Dec. 31, 2019 63,569,109 63,569,109      
Beginning balance at Dec. 31, 2019 $ 711,250 $ 63 1,197,379 (479,388) (6,804)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (in shares)   96,683      
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings 0 $ 1 (1)    
Exercise of stock options (in shares)   37,275      
Exercise of stock options 384   384    
Stock-based compensation expense 20,870   20,870    
Net loss (60,106)     (60,106)  
Foreign currency translation adjustment (16,115)       (16,115)
Ending balance (in shares) at Mar. 31, 2020   63,703,067      
Ending balance at Mar. 31, 2020 $ 656,283 $ 64 1,218,632 (539,494) (22,919)
Beginning balance (in shares) at Dec. 31, 2019 63,569,109 63,569,109      
Beginning balance at Dec. 31, 2019 $ 711,250 $ 63 1,197,379 (479,388) (6,804)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock in connection with employee stock purchase plan (in shares)   83,573      
Issuance of common stock in connection with employee stock purchase plan   $ 1,800      
Net loss (126,273)        
Foreign currency translation adjustment $ (14,711)        
Ending balance (in shares) at Jun. 30, 2020 64,300,599 64,300,599      
Ending balance at Jun. 30, 2020 $ 679,371 $ 64 1,306,483 (605,661) (21,515)
Beginning balance (in shares) at Mar. 31, 2020   63,703,067      
Beginning balance at Mar. 31, 2020 656,283 $ 64 1,218,632 (539,494) (22,919)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (in shares)   355,506      
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (463)   (463)    
Exercise of stock options (in shares)   158,453      
Exercise of stock options 1,441   1,441    
Issuance of common stock in connection with employee stock purchase plan (in shares)   83,573      
Issuance of common stock in connection with employee stock purchase plan 1,771   1,771    
Equity component of convertible senior notes, net of issuance costs 114,551   114,551    
Purchases of capped calls in connection with convertible senior notes (50,540)   (50,540)    
Stock-based compensation expense 21,091   21,091    
Net loss (66,167)     (66,167)  
Foreign currency translation adjustment $ 1,404       1,404
Ending balance (in shares) at Jun. 30, 2020 64,300,599 64,300,599      
Ending balance at Jun. 30, 2020 $ 679,371 $ 64 $ 1,306,483 $ (605,661) $ (21,515)